Company: TEM
Filing Date: 2025-08-18
Form Type: DEF 14C
Source: 0001193125-25-182684
Chunk: 2

Company: Tempus AI, Inc.
Filing Date: 2025-08-18
Form: DEF 14C
Chunk 2
---
 Record Date, there were 168,683,769 shares of Class A Common Stock issued and outstanding and 5,043,789 shares of
Class B Common Stock issued and outstanding. Our Class A Common Stock entitles holders thereof to one vote per share and our Class B Common Stock entitles holders thereof to 30 votes per share, voting together as a single class.

NO VOTE OR OTHER CONSENT OF OUR STOCKHOLDERS IS SOLICITED IN CONNECTION WITH THIS INFORMATION STATEMENT. WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

Our Board of Directors (the “Board”) unanimously approved the Amended
Articles on August 7, 2025, subject to the Company obtaining the required stockholder approval thereof. On August 8, 2025, the Majority Holder, beneficially owning 39,142,245 shares of our issued and outstanding Class A Common
Stock and 5,043,789 shares of our issued and outstanding Class B Common Stock, by written consent in lieu of a meeting (the “Written Consent”) approved the Amended Articles. As of the Record Date, the Majority Holder held
approximately 59.5% of the voting power of our outstanding capital stock. No other corporate actions to be taken by stockholder written consent were considered. Because the action was approved by the written consent of the Majority Holder
beneficially owning a majority of the voting power of our outstanding voting capital stock, no proxies are being solicited with this Information Statement. We are not aware of any substantial interest, direct or indirect, by security holders or
otherwise, that is in opposition to matters of action being taken. In addition, the action to be taken by majority written consent in lieu of a special stockholder meeting does not create any appraisal or dissenter’s rights under the NRS. The
consent we received from the Majority Holder constitutes the only stockholder approval required under the NRS, applicable Nasdaq listing rules and our current articles of incorporation (the “Current Articles”) and bylaws.

Our Board determined to pursue stockholder action by majority written consent in an effort to reduce the costs and management time required to
hold a meeting of stockholders and to implement the above action in a timely manner. Under Section 14(c) of the Exchange Act, actions taken by written consent without a meeting of stockholders cannot become effective until at least 20 calendar
days after the mailing date of this Information Statement. We are